Contact this trialFirst, we need to learn more about you.
Antibody-Drug Conjugate
REGN5093-M114 for Non-Small Cell Lung Cancer
Recruiting1 awardPhase 1 & 2
Aurora, Colorado
This trial is testing a new cancer treatment to see if it is safe and effective. The treatment is an antibody drug conjugate called REGN5093-M114 and it is being tested on patients with a certain type of lung cancer. The study has two parts, or phases. The first phase is to see if the treatment is safe and to find the best dose. The second phase is to see if the treatment works against the cancer.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.